What About HER? HER2-Targeted Treatments in Lung Cancer
Friday, October 3, 2025 |
8:15 AM - 8:40 AM |
Session Details
By the end of this session participants will be able to:
1. Describe the role of HER2 mutation, amplification, and overexpression in the development of lung cancer
2. Identify current and future HER2-targeted therapies in the treatment of lung cancer
